Prior to co-founding Triatomic, Peter invested in technology and healthcare companies across all stages for over 15 years. Between 2010 and 2020, Peter was a Senior Managing Director at Coatue Management where he managed public and private investments across tech, healthcare, consumer, and other sectors. Previously, Peter was an Analyst in the Corporate Private Equity group at Blackstone, where he worked on transactions in both the US and Asia. Peter sits on the Board of Trustees of the Cancer Research Institute, one of the first backers of cancer immunotherapy research. Peter graduated from Harvard University in 2007 with a degree in Economics.
